Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion type Assertion NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_head.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion description "[hI-con1 molecule induces strong cytotoxicity against primary chemotherapy-resistant ovarian cancer cell lines overexpressing TF and may represent a novel therapeutic agent for the treatment of ovarian tumors refractory to standard treatment modalities.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion evidence source_evidence_literature NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion SIO_000772 21725665 NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion wasDerivedFrom befree-2016 NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.
- NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_assertion wasGeneratedBy ECO_0000203 NP906933.RAQ-IgeKmyze9swBO6CEPfOiaJbWYwnI5cEuFG3EMYvfI130_provenance.